REDHILL BIOPHARMA LTD. Depreciation Expense
REDHILL BIOPHARMA LTD. (RDHL) reported Depreciation Expense of $152.00 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-05.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:DepreciationExpense · last filed 2025-09-05
- REDHILL BIOPHARMA LTD. depreciation expense for the quarter ending 2022-06-30 was $617.00K, a 32.69% increase year-over-year.
- REDHILL BIOPHARMA LTD. depreciation expense for the quarter ending 2021-06-30 was $465.00K.
| Period end | Depreciation Expense 3 month | Depreciation Expense 6 month | Depreciation Expense 12 month |
|---|---|---|---|
| 2025-06-30 | $152.00K 6-K · filed 2025-09-05 | ||
| 2024-12-31 | $588.00K 20-F · filed 2025-04-10 | ||
| 2024-06-30 | $402.00K 6-K · filed 2025-09-05 | ||
| 2023-12-31 | $1.45M 20-F · filed 2025-04-10 | ||
| 2023-06-30 | $1.05M 6-K · filed 2024-08-29 | ||
| 2022-12-31 | $2.14M 20-F · filed 2025-04-10 | ||
| 2022-06-30 | $617.00K 6-K · filed 2022-11-07 | $1.15M 6-K · filed 2023-08-17 | |
| 2021-12-31 | $1.91M 20-F · filed 2024-04-08 | ||
| 2021-06-30 | $465.00K 6-K · filed 2022-11-07 | $957.00K 6-K · filed 2022-11-07 | |
| 2020-12-31 | $1.71M 20-F · filed 2023-04-28 | ||
| 2019-12-31 | $997.00K 20-F · filed 2022-03-17 |